FORTICAL Reviews (CALCITONIN SALMON RECOMBINANT)

Average Rating: 4.0 (3 Ratings)

Filter Results

Compare FORTICAL with similar:

 Type: Rx Drug

  

FORTICAL  (CALCITONIN SALMON RECOMBINANT):  This medication is used to treat brittle bone disease (osteoporosis) in women who are at least 5 years past "the change of life" (menopause). Calcitonin works by slowing bone loss to help maintain strong bones and reduce your risk of fractures. This product has been withdrawn from the Canadian market due to safety problems.   FDA Approval Date: 2005-08-12 (Sources: U.S. Centers for Medicare Services, FDA)

  

Results are sorted by Date added.

Key to Ratings: 1=LOW (I would not recommend taking this medicine.)
5=HIGH (this medicine cured me or helped me a great deal.)

Page: 1


RATING  REASONSIDE EFFECTS FOR FORTICALCOMMENTSSEXAGEDURATION/
DOSAGE
DATE ADDED
 
 2  Osteoporosis I've been using a nasal spray for over five years. Broke a bone last year, had full body x-ray that showed no improvement in bone density. This after also taking calcium. Really disappointed.Don't know whether to try anything else. F 70
1X day
9/10/2014
 5  osteoporosis None at all. I've taken both Fortical and the generic Calcitonin Salmon and have not experienced any side effects. The Fortical smelled a little pungent, but I got used to it. For some reason the generic doesn't have that smell. I am very relieved to find a medication that I can tolerate so well. Hopefully it will help with the bone loss. F 55 2 months
1X day
11/29/2010
 5  osteoporosis Absolutely none!!!!!! One of the oldest and best meds for this condition.... F 76 4 months
1 spray 1X day
9/2/2010
  

FORTICAL  (CALCITONIN SALMON RECOMBINANT):  This medication is used to treat brittle bone disease (osteoporosis) in women who are at least 5 years past "the change of life" (menopause). Calcitonin works by slowing bone loss to help maintain strong bones and reduce your risk of fractures. This product has been withdrawn from the Canadian market due to safety problems.   FDA Approval Date: 2005-08-12 (Sources: U.S. Centers for Medicare Services, FDA)

     

BACK TO TOP